The global Synthetic Hormones market size is predicted to grow from US$ 228 million in 2025 to US$ 285 million in 2031; it is expected to grow at a CAGR of 3.7% from 2025 to 2031.

Synthetic hormones are foreign molecules that are produced in a laboratory and used to cure hormonal imbalances in men and women. Synthetic hormones such as progesterone, estrogen, thyroid hormone, testosterone, and insulin are commonly utilized to treat a variety of medical problems. These hormones are extremely active even at low doses, and long-term usage of synthetic hormones has been related to a variety of adverse effects. Some synthetic hormones on the market include Ferring B.V.s Zomacton injectable (Somatropin), which is used to treat growth hormone insufficiency in children.

The synthetic hormones market refers to the segment of the pharmaceutical industry that focuses on the development, production, and sale of synthetic or artificially produced hormones. Synthetic hormones are designed to mimic the effects of naturally occurring hormones in the body. Synthetic hormones play a crucial role in various medical treatments and therapies. They are used for a range of purposes, including hormone replacement therapy (HRT), contraception, fertility treatments, and management of hormonal disorders. Common synthetic hormones include estrogen, progesterone, testosterone, and various forms of birth control hormones. The market for synthetic hormones has witnessed significant growth in recent years due to several factors. One of the key drivers is the increasing prevalence of hormonal imbalances and disorders, such as menopause, polycystic ovary syndrome (PCOS), and hypogonadism. Additionally, the growing aging population and the increasing interest in anti-aging treatments have also contributed to the market expansion. Advancements in the field of biotechnology and pharmaceutical research have led to the development of advanced synthetic hormone formulations, including sustained-release formulations and combination therapies. These innovations offer improved efficacy, convenience, and patient compliance, further driving the market growth. The market is characterized by the presence of both generic and branded synthetic hormone products. Generic drugs are usually more affordable, leading to their widespread adoption, especially in developing regions. However, branded products continue to dominate the market in developed countries due to their brand recognition, marketing strategies, and perceived quality.

Infinity Market Research newest research report, the Synthetic Hormones Industry Forecast looks at past sales and reviews total world Synthetic Hormones sales in 2024, providing a comprehensive analysis by region and market sector of projected Synthetic Hormones sales for 2025 through 2031. With Synthetic Hormones sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Synthetic Hormones industry.

This Insight Report provides a comprehensive analysis of the global Synthetic Hormones landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Synthetic Hormones portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Synthetic Hormones market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Synthetic Hormones and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Synthetic Hormones.

This report presents a comprehensive overview, market shares, and growth opportunities of Synthetic Hormones market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Steroid Hormones
    Peptide Hormone
    Amino Acid Derivatives

Segmentation by Application:

    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Pfizer, Inc.
    McGuff Pharmaceuticals, Inc.
    Lyndra Therapeutics, Inc.
    Ferring B. V.
    Slayback Pharma
    Lupin Pharmaceuticals, Inc.
    Acerus Pharmaceuticals Corporation
    IBSA Institut Biochimique SA
    Endo International plc
    American Reagent, Inc.
    Merck Serono
    Novo Nordisk
    F. Hoffmann-La Roche
    BioPartners
    Eli Lilly

Key Questions Addressed in this Report

What is the 10-year outlook for the global Synthetic Hormones market?
What factors are driving Synthetic Hormones market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Synthetic Hormones market opportunities vary by end market size?
How does Synthetic Hormones break out by Type, by Application?